These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10466532)

  • 1. Increased F-18 FDG uptake in the stomach.
    Nunez RF; Yeung HW; Macapinlac H
    Clin Nucl Med; 1999 Apr; 24(4):281-2. PubMed ID: 10466532
    [No Abstract]   [Full Text] [Related]  

  • 2. Intense F-18 FDG accumulation in the stomach in a patient with Menetrier's disease.
    Kato T; Komatsu Y; Tsukamoto E; Takei M; Takei T; Yamamoto F; Kuge Y; Asaka M; Tamaki N
    Clin Nucl Med; 2002 May; 27(5):376-7. PubMed ID: 11953581
    [No Abstract]   [Full Text] [Related]  

  • 3. Intense F-18 FDG accumulation in stomach in a patient with Hodgkin lymphoma: Helicobacter pylori infection as a pitfall in oncologic diagnosis with F-18 FDG PET imaging.
    Ak I; Gülbaş Z
    Clin Nucl Med; 2005 Jan; 30(1):41. PubMed ID: 15604971
    [No Abstract]   [Full Text] [Related]  

  • 4. Intense F-18 FDG uptake in the stomach wall in follicular gastritis in Zollinger-Ellison syndrome.
    Basu S; Nair N
    Clin Nucl Med; 2007 Feb; 32(2):150-1. PubMed ID: 17242575
    [No Abstract]   [Full Text] [Related]  

  • 5. An analysis of the physiological FDG uptake pattern in the stomach.
    Koga H; Sasaki M; Kuwabara Y; Hiraka K; Nakagawa M; Abe K; Kaneko K; Hayashi K; Honda H
    Ann Nucl Med; 2003 Dec; 17(8):733-8. PubMed ID: 14971621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal FDG uptake in the gastric contents: a PET/CT misregistration artifact due to vesicant use and water loading.
    Kao PF; Chou YH; Hsieh KY
    Clin Nucl Med; 2008 Mar; 33(3):231-3. PubMed ID: 18287858
    [No Abstract]   [Full Text] [Related]  

  • 7. Significance of (18)F-2-deoxy-2-fluoro-glucose accumulation in the stomach on positron emission tomography.
    Takahashi H; Ukawa K; Ohkawa N; Kato K; Hayashi Y; Yoshimoto K; Ishiyama A; Ueki N; Kuraoka K; Tsuchida T; Yamamoto Y; Chino A; Uragami N; Fujisaki J; Igarashi M; Fujita R; Koyama M; Yamashita T
    Ann Nucl Med; 2009 Jun; 23(4):391-7. PubMed ID: 19399579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.
    Yun M; Choi HS; Yoo E; Bong JK; Ryu YH; Lee JD
    J Nucl Med; 2005 Jun; 46(6):953-7. PubMed ID: 15937305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant lesions can mimic gastric uptake on FDG PET.
    Chamroonrat W; Zhuang H; Houseni M; Mavi A; El-Haddad G; Bhutain C; Alavi A
    Clin Nucl Med; 2006 Jan; 31(1):37-8. PubMed ID: 16374124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary study comparing diffuse gastric FDG uptake and gastritis.
    Yasuda S; Takechi M; Ishizu K; Tanaka A; Maeda Y; Suzuki T; Sadahiro S; Ohta M; Itoh M; Makuuchi H
    Tokai J Exp Clin Med; 2008 Dec; 33(4):138-42. PubMed ID: 21318984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer.
    Larson SM; Morris M; Gunther I; Beattie B; Humm JL; Akhurst TA; Finn RD; Erdi Y; Pentlow K; Dyke J; Squire O; Bornmann W; McCarthy T; Welch M; Scher H
    J Nucl Med; 2004 Mar; 45(3):366-73. PubMed ID: 15001675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semi-quantitative measurements of normal organs with variable metabolic activity on FDG PET imaging.
    Tan LT; Ong KL
    Ann Acad Med Singap; 2004 Mar; 33(2):183-5. PubMed ID: 15098631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The increased accumulation of [18F]fluorodeoxyglucose in untreated prostate cancer.
    Oyama N; Akino H; Suzuki Y; Kanamaru H; Sadato N; Yonekura Y; Okada K
    Jpn J Clin Oncol; 1999 Dec; 29(12):623-9. PubMed ID: 10721945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive correlation between standardized uptake values of FDG uptake in the stomach and the value of the C-13 urea breath test.
    Lin CY; Liu CS; Ding HJ; Sun SS; Yen KY; Hsieh TC; Lin CC; Kao CH
    Clin Nucl Med; 2006 Dec; 31(12):792-4. PubMed ID: 17117075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidental fleurodeoxyglucose uptake in the prostate.
    Wong WL; Moule RN; Nunan T
    Br J Radiol; 2010 Nov; 83(995):902-3. PubMed ID: 20965899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enchondroma: a benign osseous lesion with high F-18 FDG uptake.
    Döbert N; Menzel C; Ludwig R; Berner U; Diehl M; Hamscho N; Grünwald F
    Clin Nucl Med; 2002 Oct; 27(10):695-7. PubMed ID: 12352108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
    Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
    J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG uptake in benign asymmetric hypertrophy of the masticator muscles.
    Ihn YK; Park YH; Chung SK
    Clin Nucl Med; 2006 Apr; 31(4):221-2. PubMed ID: 16550021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of prostate cancer using FDG-PET].
    Kanamaru H; Oyama N; Akino H; Okada K
    Hinyokika Kiyo; 2000 Nov; 46(11):851-3. PubMed ID: 11193311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of the physiological FDG uptake in the stomach with the water gastric distention method.
    Kamimura K; Fujita S; Nishii R; Wakamatsu H; Nagamachi S; Yano T; Ogita M; Umemura Y; Fujimoto T; Nakajo M
    Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1815-8. PubMed ID: 17546453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.